Company Filing History:
Years Active: 2002
Title: Kenneth B Idler: Innovator in HTLV-II Detection Methods
Introduction
Kenneth B Idler is a notable inventor based in Trevor, Wisconsin, recognized for his contributions to the field of virology. He has developed innovative methods for detecting HTLV-II antibodies, which are crucial for understanding and diagnosing certain types of leukemia.
Latest Patents
Idler holds a patent for "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel human T-cell lymphotropic virus type II isolate designated NRA, which was originally isolated from a patient with atypical hairy cell leukemia. The patent details the genetic differences between this isolate and the prototypical HTLV-II isolate Mo. It focuses on the gp46 and p21 envelope proteins encoded by the env gene, providing methods and kits for the detection of HTLV-II antibodies using these proteins.
Career Highlights
Kenneth B Idler has made significant strides in his career, particularly through his work at Abbott Laboratories Corporation. His research has contributed to advancements in the detection and understanding of HTLV-II, enhancing diagnostic capabilities in the medical field.
Collaborations
Idler has collaborated with esteemed colleagues such as Helen H Lee and Priscilla Swanson, furthering the impact of his research and innovations in the field.
Conclusion
Kenneth B Idler's work exemplifies the importance of innovation in medical diagnostics, particularly in the detection of HTLV-II antibodies. His contributions continue to influence the field and improve patient outcomes.